Citations (140)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jacopo Uliano, Eleonora Nicolò, Carla Corvaja, Beatrice Taurelli Salimbeni, Dario Trapani & Giuseppe Curigliano. (2022) Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape. Expert Review of Clinical Pharmacology 15:12, pages 1399-1413.
Read now
Read now
Nadiyah Alqazlan, Jake Astill, Sugandha Raj & Shayan Sharif. (2022) Strategies for enhancing immunity against avian influenza virus in chickens: a review. Avian Pathology 51:3, pages 211-235.
Read now
Read now
Eita Sasaki, Isao Hamaguchi & Takuo Mizukami. (2020) Pharmacodynamic and safety considerations for influenza vaccine and adjuvant design. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1051-1061.
Read now
Read now
Flavia Lozzi, Caterina Lanna, Mauro Mazzeo, Virginia Garofalo, Vincenzo Palumbo, Sara Mazzilli, Laura Diluvio, Alessandro Terrinoni, Luca Bianchi & Elena Campione. (2019) Investigational drugs currently in phase II clinical trials for actinic
keratosis. Expert Opinion on Investigational Drugs 28:7, pages 629-642.
Read now
Read now
Masaud Shah, Muhammad Ayaz Anwar, Jae-Ho Kim & Sangdun Choi. (2016) Advances in Antiviral Therapies Targeting Toll-like Receptors. Expert Opinion on Investigational Drugs 25:4, pages 437-453.
Read now
Read now
Karen AO Martins, Sina Bavari & Andres M Salazar. (2015) Vaccine adjuvant uses of poly-IC and derivatives. Expert Review of Vaccines 14:3, pages 447-459.
Read now
Read now
Julien Pothlichet & Lluis Quintana-Murci. (2013) The Genetics of Innate Immunity Sensors and Human Disease. International Reviews of Immunology 32:2, pages 157-208.
Read now
Read now
Articles from other publishers (133)
Sonia Singh, Khushi Sharma & Himanshu Sharma. (2024) Green Extracts with Metal-based Nanoparticles for Treating Inflammatory
Diseases: A Review. Current Drug Delivery 21:4, pages 544-570.
Crossref
Crossref
Aristitsa Mikhailovna Kostinova, Elena Alexandrovna Latysheva, Nelly Kimovna Akhmatova, Anna Egorovna Vlasenko, Svetlana Anatolyevna Skhodova, Ekaterina Alexandrovna Khromova, Andrey Viktorovich Linok, Arseniy Alexandrovich Poddubikov, Tatyana Vasilievna Latysheva & Mikhail Petrovich Kostinov. (2023) Expression of Toll-like Receptors on the Immune Cells in Patients with Common Variable Immune Deficiency after Different Schemes of Influenza Vaccination. Viruses 15:10, pages 2091.
Crossref
Crossref
Daniele Cavalcante Gomes, Thayse Silva Medeiros, Eron Lincoln Alves Pereira, João Felipe Oliveira da Silva, Johny W. de Freitas Oliveira, Matheus de Freitas Fernandes-Pedrosa, Marcelo de Sousa da Silva & Arnóbio Antônio da Silva-Júnior. (2023) From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease. International Journal of Molecular Sciences 24:18, pages 13778.
Crossref
Crossref
Torben Lessmann, Seth A. Jones, Tobias Voigt, Samuel Weisbrod, Oliver Kracker, Steffen Winter, Luis Alejandro Zúñiga, Sebastian Stark, Nicola Bisek & Kennett Sprogøe. (2023) Degradable Hydrogel for Sustained Localized Delivery of Anti-Tumor Drugs. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Xiang Li, Chao Pan, Caixia Li, Kangfeng Wang, Jingqin Ye, Peng Sun, Yan Guo, Jun Wu, Hengliang Wang & Li Zhu. (2023) Self-Assembled Proteinaceous Nanoparticles for Co-Delivery of Antigens and Cytosine Phosphoguanine (CpG) Adjuvants: Implications for Nanovaccines. ACS Applied Nano Materials 6:9, pages 7637-7648.
Crossref
Crossref
Saikat Manna, Sampa Maiti, Jingjing Shen, Adam Weiss, Elizabeth Mulder, Wenjun Du & Aaron P. Esser-Kahn. (2023) Nanovaccine that activates the NLRP3 inflammasome enhances tumor specific activation of anti-cancer immunity. Biomaterials 296, pages 122062.
Crossref
Crossref
Zohre Sadeghi, Mahdi Fasihi-Ramandi, Zahra Davoudi & Saeid Bouzari. (2023) Multi-Epitope Vaccine Candidates Associated with Mannosylated Chitosan and LPS Conjugated Chitosan Nanoparticles Against Brucella Infection. Journal of Pharmaceutical Sciences 112:4, pages 991-999.
Crossref
Crossref
Yudai Takase, Mirei Shirakashi, Yuri Nishida, Masao Katsushima, Hideo Onizawa, Ryosuke Hiwa, Hideaki Tsuji, Koji Kitagori, Shuji Akizuki, Akira Onishi, Ran Nakashima, Kosaku Murakami, Hajime Yoshifuji, Masao Tanaka, Tatsuaki Tsuruyama, Akio Morinobu & Motomu Hashimoto. (2022) Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible mice. Clinical Rheumatology 42:4, pages 1185-1194.
Crossref
Crossref
Yi-Bing Zhang, Yong-Rui Bao, Shuai Wang, Tian-Jiao Li, He Tai, Jia-Peng Leng, Xin-Xin Yang, Bo-Cai Wang & Xian-Sheng Meng. (2023) Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules. World Journal of Gastrointestinal Oncology 15:3, pages 504-522.
Crossref
Crossref
Yosuke Ota, Yasuhiro Nagai, Yuko Hirose, Seiji Hori, Erina Koga-Yamakawa, Ken Eguchi, Kentaro Sumida, Masashi Murata, Hiroki Umehara & Setsuko Yamamoto. (2023) DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects. Frontiers in Immunology 14.
Crossref
Crossref
Sugandha Raj, Mohammadali Alizadeh, Bahram Shoojadoost, Douglas Hodgins, Éva Nagy, Samira Mubareka, Khalil Karimi, Shahriar Behboudi & Shayan Sharif. (2023) Determining the Protective Efficacy of Toll-Like Receptor Ligands to Minimize H9N2 Avian Influenza Virus Transmission in Chickens. Viruses 15:1, pages 238.
Crossref
Crossref
Michelle L. Bookstaver, Qin Zeng, Robert S. Oakes, Senta M. Kapnick, Vikas Saxena, Camilla Edwards, Nishedhya Venkataraman, Sheneil K. Black, Xiangbin Zeng, Eugene Froimchuk, Thomas Gebhardt, Jonathan S. Bromberg & Christopher M. Jewell. (2022) Self‐Assembly of Immune Signals to Program Innate Immunity through Rational Adjuvant Design. Advanced Science 10:1.
Crossref
Crossref
Xinyuan Shen, Chaojie Zhu, Qing Wu, Jiaqi Shi, Wei Wu, Xiao Zhao, Jie Sun, Hongjun Li & Zhen Gu. (2022) Nanomodulators targeting tumor-resident immunosuppressive cells: Mechanisms and recent updates. Nano Today 47, pages 101641.
Crossref
Crossref
Lana E. Kandalaft, Denarda Dangaj Laniti & George Coukos. (2022) Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation. Nature Reviews Cancer 22:11, pages 640-656.
Crossref
Crossref
Luis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, Nicola Bisek, Enping Hong, Caroline E. Rasmussen, Jens-Jakob Karlsson, Joachim Zettler, Lars Holten-Andersen, Kathy Bang, Dhruv Thakar, Yu-Chi Lee, Salomon Martinez, Simran Singh Sabharwal, Sebastian Stark, Frank Faltinger, Oliver Kracker, Samuel Weisbrod, Robin Müller, Tobias Voigt, Kornelia Bigott, Mohammad Tabrizifard, Vibeke Miller Breinholt, Amer M. Mirza, David B. Rosen, Kennett Sprogøe & Juha Punnonen. (2022) Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction. Cancer Cell International 22:1.
Crossref
Crossref
Nirmal Das, Purbita Bandopadhyay, Swarnali Roy, Bishnu Prasad Sinha, Uddipta Ghosh Dastidar, Oindrila Rahaman, Sourav Pal, Dipyaman Ganguly & Arindam Talukdar. (2022) Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits. Journal of Medicinal Chemistry 65:17, pages 11607-11632.
Crossref
Crossref
Xiangxia Li, Guiyuan Chen, Yangyi Wang, Lanhong Su, Bo Chen, Kecheng Wu, Yun Xing, Zechenxi Song, Ruike Dai, Tianxin Liu, Jiaao Zhao, Zhe Xie, Peijie Zhou, Xiaoping Xia & Yuanzeng Min. (2022) Systematic co-delivery of dual agonists to enhance cancer immunotherapy. Nano Research 15:9, pages 8326-8335.
Crossref
Crossref
Lijia Luo, Xiang Wang, Yu-Pei Liao, Chong Hyun Chang & Andre E. Nel. (2022) Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy. ACS Nano 16:8, pages 13168-13182.
Crossref
Crossref
Shiwei Xu, Margaret C. Carpenter, Rachel L. Spreng, Scott D. Neidich, Sharanya Sarkar, DeAnna Tenney, Derrick Goodman, Sheetal Sawant, Shalini Jha, Brooke Dunn, M. Juliana McElrath, Valerie Bekker, Sarah V. Mudrak, Robin Flinko, George K. Lewis, Guido Ferrari, Georgia D. Tomaras, Xiaoying Shen & Margaret E. Ackerman. (2022) Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans. npj Vaccines 7:1.
Crossref
Crossref
Santa-Mariela Olivera-Ugarte, Marilène Bolduc, Marie-Ève Laliberté-Gagné, Léa-Jeanne Blanchette, Caroline Garneau, Maude Fillion, Pierre Savard, Isabelle Dubuc, Louis Flamand, Omar Farnòs, Xingge Xu, Amine Kamen, Mégan Gilbert, Henintsoa Rabezanahary, Martina Scarrone, Christian Couture, Mariana Baz & Denis Leclerc. (2022) A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection. Nanomedicine: Nanotechnology, Biology and Medicine 44, pages 102584.
Crossref
Crossref
Fernando Torres Andón, Sergio Leon, Aldo Ummarino, Esther Redin, Paola Allavena, Diego Serrano, Clément Anfray & Alfonso Calvo. (2022) Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists. Biomedicines 10:7, pages 1590.
Crossref
Crossref
Sashi Debnath, Guiyang Hao, Bing Guan, Pawan Thapa, Justin Hao, Hans Hammers & Xiankai Sun. (2022) Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists. International Journal of Molecular Sciences 23:13, pages 7160.
Crossref
Crossref
Weiqi Meng, Zhiping Li, Yiting Zhang, Anhui Yang, Yanzhen Wang, Yulin Zhou, Wanyue Wu, Ye Qiu & Lanzhou Li. (2022) ZhenQi FuZheng formula inhibits the growth of colorectal tumors by modulating intestinal microflora-mediated immune function. Aging 14:11, pages 4769-4785.
Crossref
Crossref
Roland Böttger, Po-Han Chao, Nojoud AL Fayez, Griffin Pauli, Anne Nguyen, Lukas Hohenwarter, Nida Bilal, Gubran Khalil Mohammed, Daniel Knappe, Ralf Hoffmann & Shyh-Dar Li. (2022) Simultaneous Chromatographic Quantitation of Drug Substance and Excipients in Nanoformulations Using a Combination of Evaporative Light Scattering and Absorbance Detectors. Molecular Pharmaceutics 19:6, pages 1882-1891.
Crossref
Crossref
Anissa S. H. Chan, Takashi O. Kangas, Xiaohong Qiu, Mark T. Uhlik, Ross B. Fulton, Nadine R. Ottoson, Keith B. Gorden, Yumi Yokoyama, Michael E. Danielson, Trinda M. Jevne, Kyle S. Michel, Jeremy R. Graff & Nandita Bose. (2022) Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies. Frontiers in Oncology 12.
Crossref
Crossref
Alessio Facciolà, Giuseppa Visalli, Antonio Laganà & Angela Di Pietro. (2022) An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines 10:5, pages 819.
Crossref
Crossref
Leila Mohammadnezhad, Mojtaba Shekarkar Azgomi, Marco Pio La Manna, Guido Sireci, Chiara Rizzo, Giusto Davide Badami, Bartolo Tamburini, Francesco Dieli, Giuliana Guggino & Nadia Caccamo. (2022) Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity. Cells 11:10, pages 1663.
Crossref
Crossref
John Victor Napoleon, Boning Zhang, Qian Luo, Madduri Srinivasarao & Philip S. Low. (2022) Design, Synthesis, and Targeted Delivery of an Immune Stimulant that Selectively Reactivates Exhausted CAR T Cells. Angewandte Chemie International Edition 61:15.
Crossref
Crossref
John Victor Napoleon, Boning Zhang, Qian Luo, Madduri Srinivasarao & Philip S. Low. (2022) Design, Synthesis, and Targeted Delivery of an Immune Stimulant that Selectively Reactivates Exhausted CAR T Cells. Angewandte Chemie 134:15.
Crossref
Crossref
Judith Stickdorn, Lara Stein, Danielle Arnold-Schild, Jennifer Hahlbrock, Carolina Medina-Montano, Joschka Bartneck, Tanja Ziß, Evelyn Montermann, Cinja Kappel, Dominika Hobernik, Maximilian Haist, Hajime Yurugi, Marco Raabe, Andreas Best, Krishnaraj Rajalingam, Markus P. Radsak, Sunil A. David, Kaloian Koynov, Matthias Bros, Stephan Grabbe, Hansjörg Schild & Lutz Nuhn. (2022) Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors. ACS Nano 16:3, pages 4426-4443.
Crossref
Crossref
Yeoul Kang, Junha Lim, Gurusamy Saravanakumar, Jinseong Kim, Mihyeon Park, Sooseok Im & Won Jong Kim. (2022) Immunostimulation of tumor microenvironment by targeting tumor-associated macrophages with hypoxia-responsive nanocomplex for enhanced anti-tumor therapy. Journal of Controlled Release 343, pages 78-88.
Crossref
Crossref
Andrew S. Mikhail, Michal Mauda-Havakuk, Ayele H. Negussie, Natalie Hong, Natalie M. Hawken, Camella J. Carlson, Joshua W. Owen, Olga Franco-Mahecha, Paul G. Wakim, Andrew L. Lewis, William F. Pritchard, John W. Karanian & Bradford J. Wood. (2022) Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization. International Journal of Pharmaceutics 616, pages 121466.
Crossref
Crossref
Ragna M.S. Haegebaert, Maxime Kempers, Wim Ceelen, Ine Lentacker & Katrien Remaut. (2022) Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer. European Journal of Pharmaceutics and Biopharmaceutics 172, pages 16-30.
Crossref
Crossref
Aubrey S Smith, Hannah M Knochelmann, Megan M Wyatt, Guillermo O Rangel Rivera, Amalia M Rivera-Reyes, Connor J Dwyer, Michael B Ware, Anna C Cole, David M Neskey, Mark P Rubinstein, Bei Liu, Jessica E Thaxton, Eric Bartee & Chrystal M Paulos. (2022)
B cells imprint adoptively transferred CD8
+
T cells with enhanced tumor immunity
. Journal for ImmunoTherapy of Cancer 10:1, pages e003078.
Crossref
Crossref
Zhongkun Zhang, Jimmy Chun-Tien Kuo, Chi Zhang, Yirui Huang, Zerui Zhou & Robert J. Lee. (2021) A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod. Pharmaceutics 13:12, pages 2060.
Crossref
Crossref
Griffin Pauli, Po-Han Chao, Zhu Qin, Roland Böttger, Suen Ern Lee & Shyh-Dar Li. (2021) Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer. Pharmaceutics 13:10, pages 1696.
Crossref
Crossref
Dandan Wan, Haiying Que, Li Chen, Tianxia Lan, Weiqi Hong, Cai He, Jingyun Yang, Yuquan Wei & Xiawei Wei. (2021) Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response. Nano Letters 21:19, pages 7960-7969.
Crossref
Crossref
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki & Taro Kawai. (2021) Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Tamara G. Dacoba, Shubaash Anthiya, Germán Berrecoso, Iago Fernández‐Mariño, Carmen Fernández‐Varela, José Crecente‐Campo, Desirée Teijeiro‐Osorio, Fernando Torres Andón & María J. Alonso. (2021) Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues. Advanced Functional Materials 31:44.
Crossref
Crossref
Abdul Samad Basheer, Faridah Abas, Iekhsan Othman & Rakesh Naidu. (2021) Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications. Cancers 13:16, pages 4226.
Crossref
Crossref
Vijayashree Mysore, Xavier Cullere, Joseph Mears, Florencia Rosetti, Koshu Okubo, Pei X. Liew, Fan Zhang, Iris Madera-Salcedo, Frank Rosenbauer, Richard M. Stone, Jon C. Aster, Ulrich H. von Andrian, Andrew H. Lichtman, Soumya Raychaudhuri & Tanya N. Mayadas. (2021) FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity. Nature Communications 12:1.
Crossref
Crossref
Despo Chatzikleanthous, Derek T. O’Hagan & Roberto Adamo. (2021) Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Molecular Pharmaceutics 18:8, pages 2867-2888.
Crossref
Crossref
Sachin Bhagchandani, Jeremiah A. Johnson & Darrell J. Irvine. (2021) Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants. Advanced Drug Delivery Reviews 175, pages 113803.
Crossref
Crossref
Vaishali Malik, Anujan Ramesh & Ashish A. Kulkarni. (2021) TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy. Advanced Therapeutics 4:8.
Crossref
Crossref
Biswajit Kundu, Deblina Raychaudhuri, Ayan Mukherjee, Bishnu Prasad Sinha, Dipika Sarkar, Purbita Bandopadhyay, Sourav Pal, Nirmal Das, Debdeep Dey, Kantubhukta Ramarao, Kasireddy Nagireddy, Dipyaman Ganguly & Arindam Talukdar. (2021) Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9. Journal of Medicinal Chemistry 64:13, pages 9279-9301.
Crossref
Crossref
Iliana K. Kerzeli, Martin Lord, Milena Doroszko, Ramy Elgendy, Aikaterini Chourlia, Ivan Stepanek, Elinor Larsson, Luuk van Hooren, Sven Nelander, Per-Uno Malmstrom, Anca Dragomir, Ulrika Segersten & Sara M. Mangsbo. (2021) Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations. PLOS ONE 16:7, pages e0253178.
Crossref
Crossref
Marwa A. Sallam, C. Wyatt Shields IV, Supriya Prakash, Jayoung Kim, Daniel C. Pan & Samir Mitragotri. (2021) A dual macrophage polarizer conjugate for synergistic melanoma therapy. Journal of Controlled Release 335, pages 333-344.
Crossref
Crossref
Dirk Theile, Lelia Wagner, Walter E. Haefeli & Johanna Weiss. (2021) In vitro evidence suggesting that the toll-like receptor 7 and 8 agonist resiquimod (R-848) unlikely affects drug levels of co-administered compounds. European Journal of Pharmaceutical Sciences 162, pages 105826.
Crossref
Crossref
DaeYong Lee, Kristin Huntoon, Yifan Wang, Wen Jiang & Betty Y. S. Kim. (2021) Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy. Advanced Materials 33:27.
Crossref
Crossref
Dhruv Varshney, Sherry Yue Qiu, Tyler P. Graf & Kevin J. McHugh. (2021) Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy. The AAPS Journal 23:4.
Crossref
Crossref
Md Abdus Subhan, Sara Aly Attia & Vladimir P. Torchilin. (2021) Advances in siRNA delivery strategies for the treatment of MDR cancer. Life Sciences 274, pages 119337.
Crossref
Crossref
Celine S. Liong, Anton A. A. Smith, Joseph L. Mann, Gillie A. Roth, Emily C. Gale, Caitlin L. Maikawa, Ben S. Ou & Eric. A. Appel. (2021) Enhanced Humoral Immune Response by High Density TLR Agonist Presentation on Hyperbranched Polymers. Advanced Therapeutics 4:4.
Crossref
Crossref
Dina V. Hingorani, Maria F. Camargo, Maryam A. Quraishi, Stephen R. Adams & Sunil J. Advani. (2021) Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs. Pharmaceutics 13:3, pages 365.
Crossref
Crossref
Hua Zhang, Wei-Lun Tang, Azadeh Kheirolomoom, Brett Z. Fite, Bo Wu, Kenneth Lau, Mo Baikoghli, Marina Nura Raie, Spencer K. Tumbale, Josquin Foiret, Elizabeth S. Ingham, Lisa M. Mahakian, Sarah M. Tam, R. Holland Cheng, Alexander D. Borowsky & Katherine W. Ferrara. (2021) Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy. Journal of Controlled Release 330, pages 1080-1094.
Crossref
Crossref
Olivia K. Burn, Kef K. Prasit & Ian F. Hermans. (2020) Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists. Cancers 12:12, pages 3824.
Crossref
Crossref
Olivier Demaria & Eric Vivier. (2020) ISACs take a Toll on tumors. Nature Cancer 2:1, pages 12-13.
Crossref
Crossref
Shuichi Tsuruoka, Jeffrey M. Purkerson & George J. Schwartz. (2020) Lipopolysaccharide directly inhibits bicarbonate absorption by the renal outer medullary collecting duct. Scientific Reports 10:1.
Crossref
Crossref
Saikat Manna, Sampa Maiti, Jingjing Shen, Wenjun Du & Aaron P. Esser-Kahn. (2020) Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity. ACS Central Science 6:11, pages 2071-2078.
Crossref
Crossref
Anthony J. Burt, Parvaneh Ahmadvand, Larissa K. Opp, Austin T. Ryan, ChulHee Kang & Rock J. Mancini. (2020) A Ligand‐Directed Nitrophenol Carbonate for Transient in situ Bioconjugation and Drug Delivery. ChemMedChem 15:21, pages 2004-2009.
Crossref
Crossref
Aric Huang, Melissa M. Pressnall, Ruolin Lu, Sebastian G. Huayamares, J. Daniel Griffin, Chad Groer, Brandon J. DeKosky, M. Laird Forrest & Cory J. Berkland. (2020) Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials. Journal of Controlled Release 326, pages 203-221.
Crossref
Crossref
Lu Wang, Ye He, Tingting He, Genhua Liu, Chuanchua Lin, Ke Li, Lu Lu & Kaiyong Cai. (2020) Lymph node-targeted immune-activation mediated by imiquimod-loaded mesoporous polydopamine based-nanocarriers. Biomaterials 255, pages 120208.
Crossref
Crossref
Tamara G. Dacoba, Clément Anfray, Francesco Mainini, Paola Allavena, María José Alonso, Fernando Torres Andón & José Crecente-Campo. (2020) Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors. Frontiers in Immunology 11.
Crossref
Crossref
Jillian L. Perry, Shaomin Tian, Nisitha Sengottuvel, Emily B. Harrison, Balachandra K. Gorentla, Chintan H. Kapadia, Ning Cheng, J. Christopher Luft, Jenny P.-Y. Ting, Joseph M. DeSimone & Chad V. Pecot. (2020) Pulmonary Delivery of Nanoparticle-Bound Toll-like Receptor 9 Agonist for the Treatment of Metastatic Lung Cancer. ACS Nano 14:6, pages 7200-7215.
Crossref
Crossref
Natasha Vinod, Duhyeong Hwang, Salma H. AzamAmanda E. D. Van Swearingen, Elizabeth WayneSloane Christian FussellMarina Sokolsky-PapkovChad V. Pecot & Alexander V. Kabanov. (2020) High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma. Science Advances 6:25.
Crossref
Crossref
Hyunjoon Kim, Vidhi Khanna, Tamara A. Kucaba, Wenqiu Zhang, Drishti Sehgal, David M. Ferguson, Thomas S. Griffith & Jayanth Panyam. (2020) TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy. Molecular Pharmaceutics 17:6, pages 2109-2124.
Crossref
Crossref
Federico L. Parra, Fernanda M. Frank, Bruno F. Alliani, Eder L. Romero & Patricia B. Petray. (2020) Imiquimod-loaded nanoarchaeosomes as a promising immunotherapy against Trypanosoma cruzi infection. Colloids and Surfaces B: Biointerfaces 189, pages 110850.
Crossref
Crossref
Bal Krishan Sharma, Naresh Kumar Kakker, Sakshi Bhadouriya & Rajesh Chhabra. (2020) Effect of TLR agonist on infections bronchitis virus replication and cytokine expression in embryonated chicken eggs. Molecular Immunology 120, pages 52-60.
Crossref
Crossref
Zhipeng Liu, Yue Xie, Yao Xiong, Siliang Liu, Chen Qiu, Zhenhao Zhu, Hua Mao, Meng Yu & Xinying Wang. (2020) TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages. Cancer Letters 469, pages 173-185.
Crossref
Crossref
Kinan Alhallak, Jennifer Sun, Barbara Muz & Abdel Kareem Azab. 2020. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics
499
526
.
Claudia Battistella, Cassandra E. Callmann, Matthew P. Thompson, Shiyin Yao, Anjana V. Yeldandi, Tomoko Hayashi, Dennis A. Carson & Nathan C. Gianneschi. (2019) Delivery of Immunotherapeutic Nanoparticles to Tumors via Enzyme‐Directed Assembly. Advanced Healthcare Materials 8:23.
Crossref
Crossref
David C. McGowan. (2019) Latest Advances in Small Molecule TLR 7/8 Agonist Drug Research. Current Topics in Medicinal Chemistry 19:24, pages 2228-2238.
Crossref
Crossref
Zohre Sadeghi, Mahdi Fasihi-Ramandi & Saeid Bouzari. (2019) Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection. International Immunopharmacology 75, pages 105829.
Crossref
Crossref
Cameron Louttit, Kyung Soo Park & James J. Moon. (2019) Bioinspired nucleic acid structures for immune modulation. Biomaterials 217, pages 119287.
Crossref
Crossref
Kyle E. Korolowizc, Bin Li, Xu Huang, Changsuek Yon, Evelyn Rodrigo, Manny Corpuz, David M. Plouffe, Bhaskar V. Kallakury, Manasa Suresh, Tom Y.‐H. Wu, Andrew T. Miller & Stephan Menne. (2019) Liver‐Targeted Toll‐Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus. Hepatology Communications 3:10, pages 1296-1310.
Crossref
Crossref
Myriam Lamrayah, Fanny Charriaud, Shangnong Hu, Simon Megy, Raphael Terreux & Bernard Verrier. (2019) Molecular modelling of TLR agonist Pam3CSK4 entrapment in PLA nanoparticles as a tool to explain loading efficiency and functionality. International Journal of Pharmaceutics 568, pages 118569.
Crossref
Crossref
Lei Yang & Jeak Ling Ding. (2019) MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling. Frontiers in Immunology 10.
Crossref
Crossref
Ondrej Uher, Veronika Caisova, Per Hansen, Jan Kopecky, Jindrich Chmelar, Zhengping Zhuang, Jan Zenka & Karel Pacak. (2019) Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity. Seminars in Oncology 46:4-5, pages 385-392.
Crossref
Crossref
Tuan Hiep Tran, Thi Thu Phuong Tran, Duy Hieu Truong, Hanh Thuy Nguyen, Tung Thanh Pham, Chul Soon Yong & Jong Oh Kim. (2019) Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy. Acta Biomaterialia 94, pages 82-96.
Crossref
Crossref
Nandita Bose, Nadine R. Ottoson, Xiaohong Qiu, Ben Harrison, Jamie R. Lowe, Mark T. Uhlik, Blaine T. Rathmann, Takashi O. Kangas, Lindsay R. Jordan, Kathleen E. Ertelt, Adria Bykowski Jonas, Richard M. Walsh, Anissa S. H. Chan, Ross B. Fulton, Steven M. Leonardo, Kathryn A. Fraser, Keith B. Gorden, Mark A. Matson, Jeremy R. Graff & Richard D. Huhn. (2019) Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers. The Journal of Immunology 202:10, pages 2945-2956.
Crossref
Crossref
Célia Jacoberger-Foissac, Hanadi Saliba, Cendrine Seguin, Anaïs Brion, Zahra Kakhi, Benoît Frisch, Sylvie Fournel & Béatrice Heurtault. (2019) Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform. International Journal of Pharmaceutics 562, pages 342-350.
Crossref
Crossref
Natalie E. Netzler, Daniel Enosi Tuipulotu & Peter A. White. (2018) Norovirus antivirals: Where are we now?. Medicinal Research Reviews 39:3, pages 860-886.
Crossref
Crossref
Matthew C. Morris, Katherine E. Cooney, Hooman Sedghamiz, Maria Abreu, Fanny Collado, Elizabeth G. Balbin, Travis J.A. Craddock, Nancy G. Klimas, Gordon Broderick & Mary Ann Fletcher. (2019) Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome. Clinical Therapeutics 41:4, pages 656-674.e4.
Crossref
Crossref
Rachel S. Riley, Carl H. June, Robert Langer & Michael J. Mitchell. (2019) Delivery technologies for cancer immunotherapy. Nature Reviews Drug Discovery 18:3, pages 175-196.
Crossref
Crossref
Kritika Gupta, Marianne Saldanha, Mruganka Parasnis, Padma V. Devarajan, Ratnesh Jain & Prajakta Dandekar. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
323
349
.
Alexander Wilkinson, Eric Lattmann, Carla B. Roces, Gabriel K. Pedersen, Dennis Christensen & Yvonne Perrie. (2018) Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01. Journal of Controlled Release 291, pages 1-10.
Crossref
Crossref
Matthew D. Morin, Ying Wang, Brian T. Jones, Yuto Mifune, Lijing Su, Hexin Shi, Eva Marie Y. Moresco, Hong Zhang, Bruce Beutler & Dale L. Boger. (2018) Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists. Journal of the American Chemical Society 140:43, pages 14440-14454.
Crossref
Crossref
Damien Carignan, Sabine Herblot, Marie-Ève Laliberté-Gagné, Marilène Bolduc, Michel Duval, Pierre Savard & Denis Leclerc. (2018) Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist. Nanomedicine: Nanotechnology, Biology and Medicine 14:7, pages 2317-2327.
Crossref
Crossref
Mikhail Petrovich Kostinov, Nelli Kimovna Akhmatova, Ekaterina Alexandrovna Khromova, Svetlana Anatolyevna Skhodova, Vera Nikolaevna Stolpnikova, Alexander Petrovich Cherdantsev & Anna Egorovna Vlasenko. 2018. Influenza - Therapeutics and Challenges. Influenza - Therapeutics and Challenges.
Tadashi Hosoya, Fumi Sato-KanekoAlast AhmadiShiyin YaoFitzgerald LaoKazutaka Kitaura, Takaji Matsutani, Dennis A. CarsonTomoko Hayashi. (2018) Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist. Proceedings of the National Academy of Sciences 115:29.
Crossref
Crossref
Jegarubee Bavananthasivam, Tamiru N. Alkie, Jake Astill, Mohamed Faizal Abdul-Careem, Sarah K. Wootton, Shahriar Behboudi, Alexander Yitbarek & Shayan Sharif. (2018) In ovo administration of Toll-like receptor ligands encapsulated in PLGA nanoparticles impede tumor development in chickens infected with Marek’s disease virus. Vaccine 36:28, pages 4070-4076.
Crossref
Crossref
Kumar Vijay. (2018) Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. International Immunopharmacology 59, pages 391-412.
Crossref
Crossref
Christopher B. Rodell, Sean P. Arlauckas, Michael F. Cuccarese, Christopher S. Garris, Ran Li, Maaz S. Ahmed, Rainer H. Kohler, Mikael J. Pittet & Ralph Weissleder. (2018) TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nature Biomedical Engineering 2:8, pages 578-588.
Crossref
Crossref
Daniel Enosi Tuipulotu, Natalie E. Netzler, Jennifer H. Lun, Jason M. Mackenzie & Peter A. White. (2018) TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation. Antimicrobial Agents and Chemotherapy 62:5.
Crossref
Crossref
Anthony J. Burt, Joseph D. Hantho, Amy E. Nielsen & Rock J. Mancini. (2018) An Enzyme-Directed Imidazoquinoline Activated by Drug Resistance. Biochemistry 57:15, pages 2184-2188.
Crossref
Crossref
Frances E Pearson, Karshing Chang, Yoshihito Minoda, Ingrid M Leal Rojas, Oscar L Haigh, Ghazal Daraj, Kirsteen M Tullett & Kristen J Radford. (2018)
Activation of human CD141
+
and CD1c
+
dendritic cells
in vivo
with combined TLR3 and TLR7/8 ligation
. Immunology and Cell Biology 96:4, pages 390-400.
Crossref
Crossref
Defne Bayik, Debra Tross & Dennis M. Klinman. (2018) Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages. Frontiers in Immunology 9.
Crossref
Crossref
Christian R. Palmer, Max E. Jacobson, Olga Fedorova, Anna M. Pyle & John T. Wilson. (2018) Environmentally Triggerable Retinoic Acid-Inducible Gene I Agonists Using Synthetic Polymer Overhangs. Bioconjugate Chemistry 29:3, pages 742-747.
Crossref
Crossref
Shannon Delaney & Mady Hornig. (2018) Environmental Exposures and Neuropsychiatric Disorders: What Role Does the Gut–Immune–Brain Axis Play?. Current Environmental Health Reports 5:1, pages 158-169.
Crossref
Crossref
John Bell, Mike Dymond, Mark Biffen, Stephen Delaney, David Keeling, Hui Zhang & Ian Robinson. (2018) Temporal cytokine and lymphoid responses to an inhaled TLR7 antedrug agonist in the cynomolgus monkey demonstrates potential safety and tolerability of this approach. Toxicology and Applied Pharmacology 338, pages 9-19.
Crossref
Crossref
Costanza Angelini, Barbara Varano, Patrizia Puddu, Maurizio Fiori, Antonella Baldassarre, Andrea Masotti, Sandra Gessani & Lucia Conti. (2017) Direct and Intestinal Epithelial Cell-Mediated Effects of TLR8 Triggering on Human Dendritic Cells, CD14+CD16+ Monocytes and γδ T Lymphocytes. Frontiers in Immunology 8.
Crossref
Crossref
Jutaek Nam, Sejin Son & James J. Moon. (2017) Adjuvant-Loaded Spiky Gold Nanoparticles for Activation of Innate Immune Cells. Cellular and Molecular Bioengineering 10:5, pages 341-355.
Crossref
Crossref
Fumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, Shannon S. Zhang, Tadashi Hosoya, Megan M. Kaneda, Judith A. Varner, Minya Pu, Karen S. Messer, Cristiana Guiducci, Robert L. Coffman, Kazutaka Kitaura, Takaji Matsutani, Ryuji Suzuki, Dennis A. Carson, Tomoko Hayashi & Ezra E.W. Cohen. (2017) Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer. JCI Insight 2:18.
Crossref
Crossref
Weidong Zhang, Myunggi An, Jingchao Xi & Haipeng Liu. (2017) Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy. Bioconjugate Chemistry 28:7, pages 1993-2000.
Crossref
Crossref
Lei Zhang, Varun Dewan & Hang Yin. (2017) Discovery of Small Molecules as Multi-Toll-like Receptor Agonists with Proinflammatory and Anticancer Activities. Journal of Medicinal Chemistry 60:12, pages 5029-5044.
Crossref
Crossref
Ranjna Madan-Lala, Pallab Pradhan & Krishnendu Roy. (2017) Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses. Scientific Reports 7:1.
Crossref
Crossref
Tamiru N. Alkie, Khaled Taha-Abdelaziz, Neda Barjesteh, Jegarubee Bavananthasivam, Douglas C. Hodgins & Shayan Sharif. (2017) Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens. PLOS ONE 12:1, pages e0169154.
Crossref
Crossref
M.A. Tomai & J.P. Vasilakos. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
149
162
.
Joseph D. Hantho, Timothy A. Strayer, Amy E. Nielsen & Rock J. Mancini. (2016) An Enzyme-Directed Imidazoquinoline for Cancer Immunotherapy. ChemMedChem 11:22, pages 2496-2500.
Crossref
Crossref
Elizabeth L. Siegler, Yu Jeong Kim & Pin Wang. (2016) Nanomedicine targeting the tumor microenvironment: Therapeutic strategies to inhibit angiogenesis, remodel matrix, and modulate immune responses. Journal of Cellular Immunotherapy 2:2, pages 69-78.
Crossref
Crossref
Ky V. Hoang, Heather Curry, Michael A. Collier, Hassan Borteh, Eric M. Bachelder, Larry S. Schlesinger, John S. Gunn & Kristy M. Ainslie. (2016) Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge. Antimicrobial Agents and Chemotherapy 60:4, pages 2052-2062.
Crossref
Crossref
Pini Matzner, Liat Sorski, Lee Shaashua, Ely Elbaz, Hagar Lavon, Rivka Melamed, Ella Rosenne, Neta Gotlieb, Amit Benbenishty, Steve G. Reed & Shamgar Ben-Eliyahu. (2016) Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects. International Journal of Cancer 138:7, pages 1754-1764.
Crossref
Crossref
Marie-Ève Lebel, Karine Chartrand, Esther Tarrab, Pierre Savard, Denis Leclerc & Alain Lamarre. (2016) Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles. Nano Letters 16:3, pages 1826-1832.
Crossref
Crossref
Dimitrios Papakostas & Eggert Stockfleth. (2015) Topical treatment of basal cell carcinoma with the immune response modifier imiquimod. Future Oncology 11:22, pages 2985-2990.
Crossref
Crossref
Neda Barjesteh, Bahram Shojadoost, Jennifer T. Brisbin, Mehdi Emam, Douglas C. Hodgins, Éva Nagy & Shayan Sharif. (2015) Reduction of avian influenza virus shedding by administration of Toll-like receptor ligands to chickens. Vaccine 33:38, pages 4843-4849.
Crossref
Crossref
Neda BarjestehJennifer T. BrisbinShahriar BehboudiÉva NagyShayan Sharif. (2015) Induction of Antiviral Responses Against Avian Influenza Virus in Embryonated Chicken Eggs with Toll-Like Receptor Ligands. Viral Immunology 28:4, pages 192-200.
Crossref
Crossref
Kui ChengMeng GaoJames I. GodfroyPeter N. BrownNoah KastelowitzHang Yin. (2015) Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists. Science Advances 1:3.
Crossref
Crossref
Kenneth Quayle, Catherine Coy, Leanna Standish & Hailing Lu. (2014) The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan. Journal of Natural Medicines 69:2, pages 198-208.
Crossref
Crossref
Yueh-Hsia Luo, Louis W. Chang & Pinpin Lin. (2015) Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications. BioMed Research International 2015, pages 1-12.
Crossref
Crossref
Samira Khiar, Nicolas Pietrancosta & Pierre-Olivier Vidalain. (2015) Stimuler la réponse interféron de type I avec des petites molécules : le renouveau d’une vieille idée. Biologie Aujourd'hui 209:2, pages 145-159.
Crossref
Crossref
Laetitia Fend, Tanja Gatard-Scheikl, Jacqueline Kintz, Murielle Gantzer, Emmanuelle Schaedler, Karola Rittner, Sandrine Cochin, Sylvie Fournel & Xavier Préville. (2014) Intravenous Injection of MVA Virus Targets CD8+ Lymphocytes to Tumors to Control Tumor Growth upon Combinatorial Treatment with a TLR9 Agonist. Cancer Immunology Research 2:12, pages 1163-1174.
Crossref
Crossref
Sebastian Kobold, Gabriela Wiedemann, Simon Rothenfußer & Stefan Endres. (2014) Modes of action of TLR7 agonists in cancer therapy. Immunotherapy 6:10, pages 1085-1095.
Crossref
Crossref
Ann L. White, Lang Dou, H. T. Claude Chan, Vikki L. Field, C. Ian Mockridge, Kane Moss, Emily L. Williams, Steven G. Booth, Ruth R. French, Elizabeth A. Potter, Cherié Butts, Aymen Al-Shamkhani, Mark S. Cragg, J. Sjef Verbeek, Peter W. M. Johnson, Martin J. Glennie & Stephen A. Beers. (2014) Fcγ Receptor Dependency of Agonistic CD40 Antibody in Lymphoma Therapy Can Be Overcome through Antibody Multimerization. The Journal of Immunology 193:4, pages 1828-1835.
Crossref
Crossref
Macarena Cobaleda-Siles, Malou Henriksen-Lacey, Ane Ruiz de Angulo, Anja Bernecker, Vanessa Gómez Vallejo, Boguslaw Szczupak, Jordi Llop, Géraldine Pastor, Sandra Plaza-Garcia, Maite Jauregui-Osoro, Levente K. Meszaros & Juan C. Mareque-Rivas. (2014) An Iron Oxide Nanocarrier for dsRNA to Target Lymph Nodes and Strongly Activate Cells of the Immune System. Small, pages n/a-n/a.
Crossref
Crossref
Brian A. Reikie, Rozanne C. M. Adams, Aleksandra Leligdowicz, Kevin Ho, Shalena Naidoo, Candice E. Ruck, Corena de Beer, Wolfgang Preiser, Mark F. Cotton, David P. Speert, Monika Esser & Tobias R. Kollmann. (2014) Altered Innate Immune Development in HIV-Exposed Uninfected Infants. JAIDS Journal of Acquired Immune Deficiency Syndromes 66:3, pages 245-255.
Crossref
Crossref
Mengyun Ke, Hui Wang, Min Zhang, Yuwei Tian, Yizhou Wang, Bing Li, Jie Yu, Jie Dou, Tao Xi & Changlin Zhou. (2014) The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo. Biochemical Pharmacology 89:1, pages 119-130.
Crossref
Crossref
Christina C.N. Wu, Brian Crain, Shiyin Yao, Mojgan Sabet, Fitzgerald S. Lao, Rommel I. Tawatao, Michael Chan, Donald F. Smee, Justin G. Julander, Howard B. Cottam, Donald G. Guiney, Maripat Corr, Dennis A. Carson & Tomoko Hayashi. (2014) Innate Immune Protection against Infectious Diseases by Pulmonary Administration of a Phospholipid-Conjugated TLR7 Ligand. Journal of Innate Immunity 6:3, pages 315-324.
Crossref
Crossref
Keith A. Feigenson, Alex W. Kusnecov & Steven M. Silverstein. (2014) Inflammation and the two-hit hypothesis of schizophrenia. Neuroscience & Biobehavioral Reviews 38, pages 72-93.
Crossref
Crossref
Abbi L. Engel, Guan-Cheng Sun, Ekram Gad, Lauren R. Rastetter, Katie Strobe, Yi Yang, Yushe Dang, Mary L. Disis & Hailing Lu. (2013) Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant. Immunobiology 218:12, pages 1468-1476.
Crossref
Crossref
Alexander Batista-Duharte, Deivys Portuondo, Iracilda Zeppone Carlos & Oliver Pérez. (2013) An approach to local immunotoxicity induced by adjuvanted vaccines. International Immunopharmacology 17:3, pages 526-536.
Crossref
Crossref
JUN LU, SHAN JIANG, SONG YE, YUN DENG, SHUAI MA & CHAO-PIN LI. (2013) CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST. Biomedical Reports 1:4, pages 609-613.
Crossref
Crossref
Joana M. Silva, Mafalda Videira, Rogério Gaspar, Véronique Préat & Helena F. Florindo. (2013) Immune system targeting by biodegradable nanoparticles for cancer vaccines. Journal of Controlled Release 168:2, pages 179-199.
Crossref
Crossref
Xuefeng Wang, Liyang Dong, Hongchang Ni, Sha Zhou, Zhipeng Xu, Jason Shih Hoellwarth, Xiaojun Chen, Rongbo Zhang, Qiaoyun Chen, Feng Liu, Jun Wang & Chuan Su. (2013) Combined TLR7/8 and TLR9 Ligands Potentiate the Activity of a Schistosoma japonicum DNA Vaccine. PLoS Neglected Tropical Diseases 7:4, pages e2164.
Crossref
Crossref
NM Berezhnaia & RI Sepiashvili. (2011) Physiology of Toll-like receptors--regulators of natural and acquired immunity. Fiziolohichnyĭ zhurnal 5:57, pages 26-29.
Crossref
Crossref